Results from a case series identified a potential association between ophthalmic complications and the rapid correction of hyperglycemia, brought on by patients using either semaglutide or tirzepatide ...

A 65-year-old female patient with type 2 diabetes mellitus and hypercholesterolemia presented with moderately graded nonproliferative diabetic retinopathy with widespread hard exudates (HEs) in the ...

The condition appears to be triggered when the optic nerve swells, choking off its blood supply because the nerve's pathway ...

Scientists remain puzzled as to why some individuals taking popular weight loss and diabetes medications such as Ozempic and ...

Popular GLP-1 medications like semaglutide and tirzepatide have been linked to rare vision issues, including NAION, raising ...

Weight-loss drugs such as semaglutides or tirzepatides may raise patients’ risk of nonarteritic anterior ischemic optic ...

Particularly, the early recognition and treatment of diabetic retinopathy or maculopathy before cataract surgery influence the final visual outcome and play a major role in perioperative decision ...

A small percentage have had vision problems, but a direct causal link with the drugs has not been established.

Physician–scientists at the University of Utah's John A. Moran Eye Center have published an investigatory review of nine patients who experienced vision complications while taking popular semaglutide ...

A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a ...